Thomas Perone
Compliance Officer at OVID THERAPEUTICS INC.
Net worth: 38 697 $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jeremy Levin | M | 70 | 10 years | |
| Megan Alexander | F | - | - | |
| Barbara Duncan | F | 59 | 7 years | |
| Jason Tardio | M | 47 | 5 years | |
| Jeffrey Rona | M | 55 | 5 years | |
| Dirk Haasner | M | 59 | 8 years | |
| Karen Bernstein | M | 71 | 9 years | |
| Robert Poole | M | 67 | 3 years | |
| Bart Friedman | M | 79 | 9 years | |
| Suzanne K. Wakamoto | F | - | 9 years | |
| Kevin Fitzgerald | M | 56 | 3 years | |
| Toshiya Nishi | M | - | 1 years | |
| Manoj Malhotra | M | - | 1 years | |
| Todd F. Baumgartner | M | - | 3 years | |
| Ann Li Lee | M | 63 | 6 years | |
| Julia Tsai | M | - | 3 years | |
| Simon D. Kelner | M | 51 | 2 years | |
| Zhaobo Wang | M | 67 |
Fairleigh Dickinson University
| 32 years |
| Zhong Zhong | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Harlan Waksal | M | 71 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 21 years |
| Jacqualyn Fouse | M | 62 | 7 years | |
| Matthew During | M | 67 | 5 years | |
| Sol Barer | M | 76 | 25 years | |
| Robert Hugin | M | 69 | 19 years | |
| Jonathan Biller | M | 61 | 8 years | |
| Timothy G. Daly | M | 52 | 6 years | |
| Scott Smith | M | 61 | 10 years | |
| Samuel D. Waksal | M | - |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 18 years |
| Perry Karsen | M | 69 | 9 years | |
| Allan Rosenthal | M | 63 |
Rutgers State University of New Jersey
| 8 years |
| Thomas Daniel | M | 70 | 10 years | |
| Peter Kellogg | M | 67 | 5 years | |
| Timothy J. Smith | M | - | - | |
| Jacquelyn Sumer | F | 46 | 1 years | |
| Ken J. Dean | M | - |
Fairleigh Dickinson University
Rutgers State University of New Jersey
| 6 years |
| Bernard M. Flynn | M | - |
Rutgers State University of New Jersey
| 3 years |
| William J. Garces | M | - |
Rutgers State University of New Jersey
| 7 years |
| Claude Nicaise | M | 71 | 8 years | |
| Ana C. Ward | F | 56 | 2 years | |
| Jay Backstrom | M | 69 | 11 years | |
| Mark Richard Frombach | M | - |
Rutgers State University of New Jersey
| 11 years |
| Joseph Paul Galda | M | 63 |
Rutgers State University of New Jersey
| 8 years |
| Philip Frost | M | 84 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 2 years |
| H. S. Wang | M | - |
Rutgers State University of New Jersey
| 4 years |
| Kenneth Jones | M | - |
Rutgers State University of New Jersey
| 7 years |
| Sandy Mahatme | M | 59 | 6 years | |
| Miles Murdocca | M | - |
Rutgers State University of New Jersey
| 5 years |
| Michael N. Needle | M | 64 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 10 years |
| Gerald F. Masoudi | M | 56 | 3 years | |
| Julia Haller | M | 69 | - | |
| Julius Mokrauer | M | - |
Rutgers State University of New Jersey
| 4 years |
| Rupert Vessey | M | 59 | 4 years | |
| Amit Rakhit | M | 54 | 5 years | |
| Brendan Delaney | M | 49 | 6 years | |
| Ronald Werner | M | - |
Rutgers State University of New Jersey
| 7 years |
| Roger Michael Matloff | M | - |
Rutgers State University of New Jersey
| 5 years |
| Craig M. Lessner | M | - |
Rutgers State University of New Jersey
| 6 years |
| Richard Morgan | M | 79 | 29 years | |
| James Terlizzi | M | 59 |
Rutgers State University of New Jersey
| 7 years |
| Michael Bonney | M | 65 | 4 years | |
| James J. Loughlin | M | 81 | 12 years | |
| Richard W. Barker | M | 75 | 7 years | |
| Ernest Mario | M | 85 | 12 years | |
| William Rastetter | M | 75 | 6 years | |
| John W. Jackson | M | 78 | 10 years | |
| Carleton A. Holstrom | M | 86 |
Rutgers State University of New Jersey
| 12 years |
| John Weiland | M | 68 | 1 years | |
| Patricia Hemingway Hall | F | 71 | 1 years | |
| Eric Rowinsky | M | 67 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 4 years |
| Rodman L. Drake | M | 80 | 8 years | |
| Lawrence V. Stein | M | 74 | 3 years | |
| Robert Hershberg | M | 61 | 5 years | |
| Carrie Cox | F | 66 | 10 years | |
| Patrick E. Flanigan | M | - | - | |
| Daniel Lynch | M | 65 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 4 years |
| Douglas Williams | M | 66 | 5 years | |
| Michael Friedman | M | 80 | 8 years | |
| Ross Haghighat | M | 60 |
Rutgers State University of New Jersey
| 5 years |
| Daniel O'Connor | M | 59 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 6 years |
| Gordon M. Russo | M | - |
Rutgers State University of New Jersey
| 4 years |
| Dave Yeager | M | - |
Rutgers State University of New Jersey
| 4 years |
| Mitch Livingston | M | - |
Rutgers State University of New Jersey
| 4 years |
| Jim Laman | M | - |
Rutgers State University of New Jersey
| 4 years |
| Mary Pat Fralick | F | - |
Rutgers State University of New Jersey
| 4 years |
| Jeff M. Pollock | M | - |
Rutgers State University of New Jersey
| 4 years |
| Christian E. Plaza | M | - |
Rutgers State University of New Jersey
| 4 years |
| Michael Galtman | M | 49 |
Rutgers State University of New Jersey
| 4 years |
| Steven Abrams | M | 56 |
Rutgers State University of New Jersey
| 4 years |
| Jim Xiong | M | - |
Rutgers State University of New Jersey
| 7 years |
| Mark Fields | M | 63 |
Rutgers State University of New Jersey
| 4 years |
| David Eugene Pasi | M | 63 |
Rutgers State University of New Jersey
| 4 years |
| Edward Rebar | M | 56 |
Rutgers State University of New Jersey
| 4 years |
| Gregg E. Bullwinkel | M | - |
Rutgers State University of New Jersey
| 4 years |
| Dong-Il Kim | M | 65 |
Rutgers State University of New Jersey
| 3 years |
| Charles Stanley Bailey | M | 75 |
Rutgers State University of New Jersey
| 4 years |
| Charles Zimmerman | M | - |
Rutgers State University of New Jersey
| 4 years |
| Joe Rotondo | M | - |
Rutgers State University of New Jersey
| 4 years |
| Steven Charles DeLuca | M | 60 |
Rutgers State University of New Jersey
| 4 years |
| Barbara J. M. Masekela | F | 82 |
Rutgers State University of New Jersey
| 10 years |
| B. Mitchell | M | 62 |
Rutgers State University of New Jersey
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Thomas Perone
- Personal Network
